MedPath
HSA Approval

DBL CARBOPLATIN INJECTION 10 mg/ml

SIN02301P

DBL CARBOPLATIN INJECTION 10 mg/ml

DBL CARBOPLATIN INJECTION 10 mg/ml

August 16, 1988

PFIZER PRIVATE LIMITED

PFIZER PRIVATE LIMITED

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantPFIZER PRIVATE LIMITED
Licence HolderPFIZER PRIVATE LIMITED

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INJECTION

INTRAVENOUS

Medical Information

L01XA02

carboplatin

Manufacturer Information

PFIZER PRIVATE LIMITED

Hospira Australia Pty Ltd

Active Ingredients

Carboplatin

10 mg/ml

Carboplatin

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.